Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient With ST-Segment Elevation Myocardial Infarction

Heparin is an essential drug in the treatment of acute coronary syndrome and it is used during percutaneous coronary intervention (PCI). Heparin-induced thrombocytopenia (HIT), albeit a serious complication of heparin therapy characterized by thrombocytopenia and high risk for venous and arterial th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hong Won, Yoon, Hyuck Jun, Choi, Sang Woong, Bae, Han Jun, Sohn, Ji Hyun, Lee, Ho Myung, Cho, Hyun Ok, Cho, Yun Kyeong, Park, Hyoung Seob, Kim, Hyungseop, Nam, Chang Wook, Hur, Seung Ho, Kim, Yoon Nyun, Kim, Kwon Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467452/
https://www.ncbi.nlm.nih.gov/pubmed/23091513
http://dx.doi.org/10.4070/kcj.2012.42.9.646
Descripción
Sumario:Heparin is an essential drug in the treatment of acute coronary syndrome and it is used during percutaneous coronary intervention (PCI). Heparin-induced thrombocytopenia (HIT), albeit a serious complication of heparin therapy characterized by thrombocytopenia and high risk for venous and arterial thrombosis, has rarely been previously reported during PCI. We report a case of an acute stent thrombosis due to an unusual cause, HIT during primary PCI, in a patient with acute myocardial infarction.

Ejemplares similares